Psychemedics Corporation
PMDI
$2.30
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.18M | 4.73M | 5.36M | 5.00M | 5.70M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.18M | 4.73M | 5.36M | 5.00M | 5.70M |
| Cost of Revenue | 3.14M | 3.18M | 3.24M | 2.94M | 3.61M |
| Gross Profit | 2.04M | 1.55M | 2.12M | 2.06M | 2.09M |
| SG&A Expenses | 2.46M | 2.26M | 2.48M | 2.64M | 2.92M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.77M | 5.63M | 5.92M | 5.87M | 6.81M |
| Operating Income | -595.00K | -899.00K | -567.00K | -868.00K | -1.11M |
| Income Before Tax | -606.00K | -898.00K | -572.00K | -876.00K | -1.11M |
| Income Tax Expenses | -71.00K | -71.00K | 116.00K | 69.00K | 992.00K |
| Earnings from Continuing Operations | -535.00K | -827.00K | -688.00K | -945.00K | -2.10M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -535.00K | -827.00K | -688.00K | -945.00K | -2.10M |
| EBIT | -595.00K | -899.00K | -567.00K | -868.00K | -1.11M |
| EBITDA | -302.00K | -595.00K | -246.00K | -743.00K | -656.00K |
| EPS Basic | -0.09 | -0.14 | -0.12 | -0.16 | -0.36 |
| Normalized Basic EPS | -0.06 | -0.10 | -0.06 | -0.09 | -0.12 |
| EPS Diluted | -0.09 | -0.14 | -0.12 | -0.16 | -0.36 |
| Normalized Diluted EPS | -0.06 | -0.10 | -0.06 | -0.09 | -0.12 |
| Average Basic Shares Outstanding | 5.89M | 5.82M | 5.81M | 5.81M | 5.76M |
| Average Diluted Shares Outstanding | 5.89M | 5.82M | 5.81M | 5.81M | 5.76M |
| Dividend Per Share | -- | -- | -- | 0.00 | 0.00 |
| Payout Ratio | -- | -- | -- | 0.00% | 0.00% |
